Phase III PAOLA-1/ENGOT-ov25 trial: Olaparib plus bevacizumab as maintenance therapy in patients with newly diagnosed, advanced ovarian cancer treated with platinum-based chemotherapy plus bevacizumab

You are here:
Go to Top